porcine circovirus type 1-type 2b chimera inactivated
zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated - unknown - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 0.0 - active constituent
fostera gold pcv metastim
zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated; porcine circovirus type 1-type 2a chimera inactivated; thiomersal - misc. vaccines or anti sera - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 1.0 rp; porcine circovirus type 1-type 2a chimera inactivated active 1.0 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy
fostera gold pcv mh
zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated; porcine circovirus type 1-type 2a chimera inactivated; mycoplasma hyopneumoniae - inactivated antigen; thiomersal - misc. vaccines or anti sera - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 1.0 rp; porcine circovirus type 1-type 2a chimera inactivated active 1.0 rp; mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 1.5 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy
fostera gold pcv formulation: each 2 ml (dose) contains: inactivated porcine circovirus (pcv) (type 1-2 chimera)........... ≥ 1.3 rp (type 1-2b chimera)...............≥ 1.3 rp rp-relative potency suspension for injection (im)
zoetis philippines inc.; distributor: zoetis philippines inc. - porcine circovirus (pcv) inactivated chimera vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: inactivated porcine circovirus (pcv) (type 1-2 chimera)........... ≥ 1.3 rp (type 1-2b chimera)...............≥ 1.3 rp rp-relative potency
porcine circovirus type 2 orf2 subunit antigen
intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - unknown - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 0.0 - active constituent
ingelvac circoflex suspension for injection in pigs
boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein; carbomer - misc. vaccines or anti sera - porcine circovirus type 2 orf2 protein vaccine-viral active 1.0 ml/do; carbomer ungrouped other 1.0 mg - immunotherapy - pigs - see label for type - disease control
fostera gold pcv-mh formulation: each 2 ml (dose) contains: porcine circovirus (genotype 1 and type 2, 2b chimera)........ 1>.3 rp mesomycoplasma hyopneumoniae (p-5722-3 strain).............. > 1.8 rp rp - relative potency emulsion for injection (im)
zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated porcine circovirus (pcv) , mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: porcine circovirus (genotype 1 and type 2, 2b chimera)........ 1>.3 rp mesomycoplasma hyopneumoniae (p-5722-3 strain).............. > 1.8 rp rp - relative potency
porcilis pcv m hyo
intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)
ingelvac circoflex each dose (1 ml) contains: porcine circovirus type 2 orf2 protein *rp-relative potency suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated recombinant porcine circovirus type 2 (pcv2) vaccine (vet.) - suspension for injection (im) - each dose (1 ml) contains: porcine circovirus type 2 orf2 protein *rp-relative potency
ingelvac circoflex-mycoflex processed under fda memorandum circular 2021-001. formulation: each 2 ml (dose) contains: porcine circovirus type 2, orf 2........................>1 rp mesomycoplasma hyopneumoniae (b-3745 isolate, j strain) .........> 1rp rp - relative potency suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated porcine circovirus type 2 (pcv2) mesomycoplasma hyopneumoniae vaccine (vet.) - suspension for injection (im) - processed under fda memorandum circular 2021-001. formulation: each 2 ml (dose) contains: porcine circovirus type 2, orf 2........................>1 rp mesomycoplasma hyopneumoniae (b-3745 isolate, j strain) .........> 1rp rp - relative potency